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Background:  Propofol and barbiturates are both known to protect cells of several organs against ischemia/
reperfusion injury, but there are few reports on any possible protective effects on human hepatocytes.  We 
investigated the activities of both agents on human hepatic SNU761 cells under hydrogen peroxide (H2O2)-induced 
oxidative stress.
Methods:  To determine whether propofol and pentobarbital protect hepatocytes from H2O2-induced toxicity, 
we used SNU761 cells, a human hepatocellular carcinoma (HCC) cell line. Cells were pretreated with different 
dosages (1, 10, 50 μM) of propofol or pentobarbital (1, 10, 50, 100, 400 μM) 30 min before H2O2 application. Lactate 
dehydrogenase (LDH) was measured to assess and quantify cell death. To determine the nature of cell death, treated 
hepatocytes were doubly stained with fluorescein isothiocyanate (FITC)-labeled Annexin V and propidium iodide 
(PI), and analyzed by flow cytometry.
Results:  Pretreatment with propofol, but not pentobarbital, suppressed H2O2-induced LDH release. In Annexin 
V-FITC/PI binding analysis, propofol decreased the number of necrotic and late apoptotic cells, but no significant 
decreases in such cell numbers were seen when pentobarbital was used. 
Conclusions:  Unlike pentobarbital, propofol, at clinical concentrations, protected SNU-761 HCC cells against 
oxidative stress.  (Korean J Anesthesiol 2010; 58: 277-282)
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Introduction
    Liver injury caused by oxidative stress may occur under many 
clinical conditions, including liver surgery, transplantation 
surgery, the use of extracorporeal circulation in cardiac or 
vascular surgery and hemorrhagic, cardiogenic, or septic 
shock states followed by resuscitation [1,2], and it could 
increase the morbidity and mortality of patient [3,4]. Although 
hepatocytes have an antioxidant defence system to remove or 
neutralize reactive oxygen species (ROS), excessive production 
of ROS such as hydrogen peroxide (H2O2), occurring during 
the reperfusion period, results in an imbalance between 
pro-oxidants and antioxidants and usually leads to cellular 
dysfunction and tissue injury [5]. Thus, suppression of oxidative 
stress caused by ROS could reduce liver damage and ameliorate 
outcome of patients. 
    Propofol (2, 6-diisopropylphenol) and barbiturate, highly 
lipid-soluble anaesthetics, are both known to have antioxidant 
activities, protecting against lipid peroxidation [6], and both 
agents are often used in several clinical conditions to reduce 
cerebral edema during liver transplantation in fulminant 
hepatic failure (FHF) patients [7,8]. However, whether the 
antioxidant activities of propofol and pentobarbital protect 
hepatocytes exposed to oxidative stress is unclear. 
    Cell death can be categorized into apoptosis and necrosis. 
Apoptosis, or programmed cell death, is an active process 
characterized by cytoplasmic shrinkage, chromatin 
condensation, nuclear fragmentation, and activation of 
caspases [9]. In addition, phosphatidylserine (PS) is exposed 
on the external surface of the cell in the early phase of 
apoptosis, and this exposure precedes membrane damage 
and DNA fragmentation [10]. On the other hand, necrosis is 
passive, and is characterized by cell swelling, rupture of the 
plasma membrane, and cell lysis, with leakage of cytoplasmic 
components such as lactate dehydrogenase (LDH) [9].
    It is known that direct exposure of hepatocytes to exogenous 
oxidants including H2O2 can induce both apoptotic and necrotic 
cell death [11]. In the current study, we explored the modes 
of cell death (apoptosis and/or necrosis) induced by H2O2 in 
hepatic cell and compared the protective effects of propofol and 
pentobarbital. 
Materials and Methods
    Propofol was obtained from AstraZeneca Pharmaceuticals 
(Macclesfield, Cheshire, UK), and pentobarbital sodium 
salt was from Sigma (St. Louis, MO, USA). The LDH assay kit 
(CytoTox 96
Ⓡ Non-Radioactive Cytotoxicity Assay) was from 
Promega (Madison, WI, USA). RPMI-1640 with L-glutamine, 
fetal bovine serum, and an antibiotic-antimycotic mixture 
(penicillin-streptomycin-amphotericin B) were purchased from 
Gibco BRL (New York, NY, USA). H2O2 was purchased from 
Sigma. Fluorescein isothiocyanate (FITC)-labeled Annexin V 
and propidium iodide (PI) were from BD Biosciences (San Jose, 
CA, USA).
    The SNU-761 human hepatocellular carcinoma (HCC) cell 
line was purchased from the Korean Cell Line Bank [12]. Cells 
were cultured in RPMI-1640 with L-glutamine (300 mg/L) and 
HEPES (25 mM) containing 10% (v/v) fetal bovine serum and 
10,000 units/ml of penicillin, 10,000 μg/ml of streptomycin, and 
25 μg/ml of amphotericin B at 37
oC in a humidified incubator 
under 95% air/5% CO2. Culture medium was replaced every 2 
days. Three days after plating, cells were challenged with H2O2 
at variable concentrations and different durations. 
    Varying concentrations of propofol (1, 10, 50 μM) or pento-
barbital (10, 50, 100, 400 μM) were added to cell culture 
medium. Before induction of cell death by H2O2 (125 μM), cells 
were pretreated with different drug doses for 30 min and H2O2 
was then added; incubation continued for 6 h. 
    LDH is normally present in the cytoplasm of hepatocytes. In 
response to cell damage, LDH is released from cells. Therefore, 
to measure necrotic cell death, we assayed LDH levels and 
calculated percentages of LDH release to the medium. 
LDH activity was measured spectrophotometrically using a 
commercial kit. The percentage of LDH release was calculated 
by [LDH]test/[LDH]control × 100 where [LDH]test was the LDH level 
of the test medium and [LDH]control was the measured LDH level 
in control medium.
    To assess the cell death modes induced by H2O2, treated 
SNU-761 HCC cells were doubly stained with Annexin V-FITC 
and PI and analyzed by flow cytometry. Exposure of PS on the 
external cell surface occurs in the early phase of apoptotic cell 
death, during which time the cell membrane remains intact 
[13]. Therefore, simultaneous use of Annexin V (which binds 
specifically to PS) and a non-vital dye (such as PI; exclusion of 
the dye from cells indicates cell membrane integrity) is valuable 
in discriminating between apoptosis and necrosis [10]. 
    Annexin V-FITC/PI double staining of cells was achieved 
using an Annexin V-FITC apoptosis detection kit. Briefly, both 
floating and adherent cells were collected and analyzed; 1 × 
10
6 cells/well were plated on a 12-well plate. Cells were washed 
with PBS and collected by trypsinization. After centrifugation at 
400 × g for 5 min at 4°C, cells were washed twice with cold PBS 
and resuspended in 1 x Annexin V binding buffer. One hundred 
microliter amounts of cell suspension were transferred to test 
tubes to which were added 5 μl of FITC-labeled Annexin V and 
5 μl of PI solution. The cells were gently vortexed and incubated 
for 15 min at room temperature in the dark. After addition of 
200 μl 1 x binding buffer to each tube, cells were analyzed on 
a FACSCalibur flow cytometer (BD Biosciences, San Jose, CA, 279 www.ekja.org
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USA). Annexin V-FITC and PI emissions were detected in the 
FL 1 and FL 2 channels. The Annexin V-FITC-/PI- population 
was considered to reflect normal healthy cells, whereas Annexin 
V-FITC+/PI- cells were taken to show early apoptosis. Annexin 
V-FITC+/PI+ cells were in late apoptosis or necrosis, whereas 
Annexin V-FITC-/PI+ cells were necrotic [11]. The percentages 
of normal, early apoptotic, late apoptotic, and necrotic cells 
were calculated using the CellQuest Pro software program (r 
2000 Becton Dickinson, Hertfordshire, UK).
    Statistical analyses were performed employing the SigmaStat 
program (version 3.10; Systat software; Chicago, IL, USA). 
Multiple groups were compared using one-way analysis of 
variance (ANOVA) or the Kruskal-Wallis one-way ANOVA on 
ranks followed by multiple comparisons using the Tukey post 
hoc test when appropriate. For all comparisons, a P value less 
than 0.05 was considered statistically significant. Data shown 
are mean ± SD unless stated otherwise.
Results
    Pretreatment with propofol at 1, 10, or 50 μM gradually 
suppressed H2O2-induced LDH release, with the two higher 
concentrations showing significant release inhibition (P < 
0.05) (Fig. 1A). Pretreatment with pentobarbital at 10, 50, or 
100 μM did not suppress H2O2-induced LDH release; in fact, 
pentobarbital at 400 μM significantly (P < 0.05) increased such 
release (Fig. 1B).
    Annexin V-FITC binding analysis and PI staining were 
performed to identify cells undergoing apoptotic and necrotic 
death, respectively. SNU-761 HCC cells were treated with 0, 
125, or 250 μM of H2O2 for 6 h and next stained with Annexin 
V-FITC/PI. As shown in Fig. 2, H2O2 decreased the proportion 
of normal cells, and increased the percentages of apoptotic and 
necrotic cells, in a dose-dependent manner.
    After treatment of SNU-761 HCC cells with H2O2 for 6 h at 
a concentration of 125 μM, necrotic and late apoptotic cells 
increased in number. As shown in Fig. 2, propofol decreased 
these numbers (P < 0.05), but pentobarbital caused no 
significant decrease in numbers of necrotic or apoptotic cells. 
Discussion
    In this study, we examined and compared the effects of 
propofol and pentobarbital on hepatocyte death induced 
by H2O2 in vitro. The results indicate that propofol, but not 
pentobarbital, exerts a protective effect on hepatocytes exposed 
to H2O2 oxidant stress. 
    To investigate possible protective roles of propofol and 
pentobarbital during oxidant-mediated cell death, we used 
H2O2 as a stress inducer. ROS, including H2O2, cause a variety 
of cell and tissue injuries, and hepatocytes are susceptible to 
H2O2-induced damage. High levels of H2O2 probably overwhelm 
cellular antioxidant defenses, leading to cellular dysfunction 
and cytotoxicity [14]. H2O2 can induce apoptosis and necrosis in 
hepatocytes [15], and the relative proportions of the cell death 
modes may be determined by insult intensity and cell type [11]. 
We found that 6 h exposure to 125 μM H2O2 caused apoptosis 
and necrosis of SNU-761 HCC cells. To explore possible 
Fig. 1.  Effects of propofol and pentobarbital on LDH release from hepatocytes after exposure to 125 μM H2O2 for 6 h. Propofol decreased 
LDH release in a dose-dependent manner (A), but pentobarbital did not (B). Values are mean ± SD. H2O2: hydrogen peroxide, LDH: lactate 
dehydrogenase, P: propofol, Pe: pentobarbital. *P < 0.05 compared with H2O2-untreated cells (control), 
†P < 0.05 compared with H2O2-treated 
cells (no drug). 280 www.ekja.org
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protective effects of propofol in cells under oxidative stress, 
we chose the range 1-50 μM (0.178-8.90 μg/ml) as clinically 
relevant because peak plasma concentrations of propofol 
are reportedly 40-60 μM (7.12-10.68 μg/ml) at anaesthesia 
induction and 10-25 μM (1.78-4.45 μg/ml) during anaesthesia 
maintenance [16,17]. Our results are not, however, in full 
agreement with previous studies, which yielded conflicting data 
regarding the effects of propofol on the liver under oxidative 
stress [18-20]. Navapurkar and co-workers [17] demonstrated 
that propofol could protect suspensions of isolated rat 
hepatocytes from an oxidant insult. Also, Wang and co-workers 
[20] reported that propofol had an anti-apoptotic effect on 
human hepatic L02 cells suffering from oxidant stress induced 
by H2O2; this was mediated by activation of extracellular 
signal-regulated kinase pathways. However, in an ischemia/
reperfusion (I/R) model using the precision-cut rat liver-slice 
technique, propofol did not show any beneficial effect against 
I/R injury [19]. Reasons for these discrepancies may include 
the use of different experimental models. For example, liver 
slices are multi-layered, and include not only hepatocytes, but 
also other cell types (such as Kupffer cells and neutrophils) that 
inhibit the antioxidant effects of propofol [19]. 
    In the present study, pentobarbital did not protect 
hepatocytes from oxidative stress; rather, this drug aggravated 
stress damage when present at a high concentration (400 μM). 
This concentration is comparable with the plasma level during 
barbiturate coma. Although central nervous system levels 
of pentobarbital during drug therapy are largely unknown, 
Fig. 2. Apoptosis and necrosis induced 
by H2O2 and effects of propofol or 
pentobarbital on H2O2-induced cell 
death in hepatocytes. The figure shows 
flow cytometric analysis of Annexin 
V-FITC/PI doubly stained cells. Cells 
were either untreated (controls) or 
treated with 125, 250 μM H2O2 for 6 h 
or were pretreated with propofol (50 
μM) or pentobarbital (400 μM) for 
30 min followed by exposure to H2O2 
(125 μM) for 6 h. The percentages of 
the cell forms mentioned below were 
calculated using the CellQuest Pro 
software program (mean values are 
given; the experiment was performed 
three times). In each plot, the lower left 
quadrant represents viable cells, the 
upper left quadrant necrotic cells, the 
lower right quadrant early apoptotic 
cells, and the upper right quadrant 
necrotic or late apoptotic cells. H2O2: 
hydrogen peroxide, FITC: fluorescein 
isothiocyanate, PI: propidium iodide.281 www.ekja.org
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common therapeutic plasma concentrations have been 
reported to be 144-323 μM [21]. Therefore, we considered 
1-400 μM of pentobarbital to be the clinically relevant range. 
Our results are consistent with those of a previous study 
showing that pentobarbital aggravates neuronal cell damage 
after combined oxygen and glucose deprivation [6]. Further 
work exploring the detrimental effects of pentobarbital may be 
warranted. 
    When the clinical implications of our data are considered, 
it may be that propofol is a better anesthetic choice than 
pentobarbital during surgery that involves temporary 
interruption of liver blood flow. In addition, pentobarbital has 
usually been employed to reduce cerebral edema during liver 
transplantation in FHF patients, but we may be more cautious 
attitude to use of pentobarbital in liver surgery. Delayed 
wakefulness and postoperative neurologic examination are 
caused by the very long drug half-life, and pentobarbital use 
is also associated with significant hemodynamic disturbances 
[7,8]. Therefore, some recent reports have suggested that 
propofol might be a useful alternative for reduction of cerebral 
edema because propofol metabolism is not greatly affected 
by liver failure [8,22]. In the present study, our data support 
the idea that propofol may be more useful than pentobarbital 
in patients with FHF. However, a further in vivo study is 
needed to establish which anaesthetics are suitable for use 
in hepatic surgery, particularly in FHF cases, during which 
interruption of liver blood flow is planned, because the in 
vitro and in vivo effects of anesthetics can differ [23]. Also it is 
another consideration that we used the tumor cells of human 
hepatocytes. In other words, different results might have made 
in our research if we had used normal human hepatocytes.
    In conclusion, pentobarbital did not affect apoptosis or 
necrosis induced by H2O2, and, at low concentrations, was not 
cytotoxic for hepatocytes, whereas propofol preconditioning 
was protective in a dose-dependent manner. Our results show 
that propofol protects hepatocytes in vitro in the clinically 
relevant range 10-50 μM, suggesting potential benefits when 
the drug is employed during liver surgery, especially in FHF 
patients. 
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